To assess the patient-level and societal burden of atopic dermatitis, we comprehensively
reviewed the literature related to quality of life, social, economic, academic, and occupational …

Background Numerous population-based studies have documented high prevalence of scabies
in overcrowded settings, particularly among children and in tropical regions. We provide …

Importance Systemic treatments for atopic dermatitis are being evaluated primarily in
placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates …

Systematic reviews are increasingly utilized in the medical literature to summarize available
evidence on a research question. Like other studies, systematic reviews are at risk for bias …

Background Although most patients with atopic dermatitis (AD) are effectively managed with
topical medication, a significant minority require systemic therapy. Guidelines for decision …

… Author links open overlay panel Dawn MR Davis MD (Co-Chair) a , Aaron M. Drucker MD,
ScM b c , Ali Alikhan MD d , Lionel Bercovitch MD e , David E. Cohen MD, MPH f , Jennifer …

Photo-induced drug eruptions are cutaneous adverse events due to exposure to a drug and
either ultraviolet or visible radiation. Based on their pathogenesis, they can be classified as …

From M arch to A ugust 2010, there was a shortage of encapsulated liquid 8‐methoxypsoralen
(8‐ MOP ), the psoralen used for bath psoralen plus UVA ( PUVA ) in T oronto, C anada. …

Importance Most clinical trials assessing systemic immunomodulatory treatments for patients
with atopic dermatitis are placebo-controlled. Objective To compare the effectiveness and …

Background Systemic corticosteroids are often used to treat atopic dermatitis (AD). However,
few studies have assessed the safety and efficacy of systemic corticosteroids in AD. …